Posters
« Back
Anti-HER2 ADC preparation and potency evaluation against HER2 overexpression human cancer cell lines
EP37875
Poster Title: Anti-HER2 ADC preparation and potency evaluation against HER2 overexpression human cancer cell lines
Submitted on 23 Nov 2021
Author(s): Creative Biolabs
Affiliations:
This poster was presented at https://www.creative-biolabs.com/adc
Poster Views: 246
View poster »


Poster Information
Abstract: In clinical diagnosis, prior to treatment, patients are examined via a series of clinical diagnostic tests. In breast cancer, detection of breast cancer-associated biomarkers is of great significance and human epidermal growth factor receptor 2 (HER2) is particularly important.https://www.creative-biolabs.com/adc/anti-her2-antibody-development.htmSummary: In clinical diagnosis, prior to treatment, patients are examined via a series of clinical diagnostic tests. In breast cancer, detection of breast cancer-associated biomarkers is of great significance and human epidermal growth factor receptor 2 (HER2) is particularly important.https://www.creative-biolabs.com/adc/anti-her2-antibody-development.htmReport abuse »
Questions
Ask the author a question about this poster.
Ask a Question »

Creative Commons

Related Posters


Generating antimicrobial peptides using generative adversarial networks.
Khondamir Rustamov

PBPK/RO modeling of anti-PDL1 antibodies
Antonina Nikitich, Oleg Demin Jr

In silico identification and characterization of epitope-based peptide of Buffalo TLR4
Shipra Chauhan, Prashant Kumar, Prashant Singh, Anuradha Bhardwaj, Sanjay Kumar, Navneet Saxena, Dharmendra Kumar, Sajjan Singh, T.K.. Datta, Varij Nayan

Development of QSP model of COVID-19 based on Immune Response Template
Veronika Musatova, Oleg Demin, Maria Kupriyanova, Anna Viktorenko

A brief introduction to non-IgG antibody
Candy Swift

© 2022 Technology Networks Ltd.
Privacy Policy & Disclaimer